Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02415400
Other study ID # CV185-316
Secondary ID 2014-002004-24
Status Completed
Phase Phase 4
First received
Last updated
Start date June 4, 2015
Est. completion date November 10, 2018

Study information

Verified date June 2020
Source Bristol-Myers Squibb
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if Apixaban is safer than a Vitamin K Antagonist given for 6 months in terms of bleeding in patients with an irregular heart beat (atrial fibrillation) and a recent heart attack or a recent procedure to open up a blood vessel in the heart. All patients would also be taking a class of medicines called P2Y12 inhibitors (such as clopidogrel/Plavix) and be treated for up to 6 months. The primary focus will be a comparison of the bleeding risk of Apixaban, with or without aspirin, versus a Vitamin K antagonist, such as warfarin, with or without aspirin.


Description:

Patients will be recruited from either inpatient coronary care or general medical units, or recruited from outpatient cardiology offices.

Masking:

Apixaban: Open label.

VKA: Open label.

Acetylsalicylic acid film coated tablet: Double Blinded.

Placebo matching Acetylsalicylic acid film coated tablet: Double Blinded.


Recruitment information / eligibility

Status Completed
Enrollment 4614
Est. completion date November 10, 2018
Est. primary completion date November 10, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

- Adults with either active or a history of non-valvular atrial fibrillation or flutter with the planned or existing use of an oral anticoagulant for prophylaxis of thromboembolism. In addition, subjects must have had an acute coronary syndrome or percutaneous coronary intervention with a stent within the prior 14 days

- Planned use of antiplatelet agents for at least 1 to 6 months

- Males and Females = 18 years of age

- Women of childbearing potential must have a negative serum or urine pregnancy test within 24 hours prior to the start of study drug

Exclusion Criteria:

- Conditions other than atrial fibrillation that require chronic anticoagulation. (e.g. prosthetic mechanical heart valve)

- Severe renal insufficiency (serum creatinine > 2.5 mg/dL or a calculated creatinine clearance < 30 mL/min

- Patients with a history of intracranial hemorrhage

- Patients have had or will undergo Coronary arterial bypass graft (CABG) for their index acute coronary syndrome (ACS) event

- Patients with known ongoing bleeding and patients with known coagulopathies

- Any contraindications or allergies to VKA, apixaban, or to intended P2Y12 antagonists or to aspirin

Study Design


Intervention

Drug:
Apixaban

vitamin K antagonist

Acetylsalicylic acid

Other:
Acetylsalicylic acid placebo


Locations

Country Name City State
Argentina Local Institution Bahia Blanca Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires
Argentina Local Institution Buenos Aires BUA
Argentina Local Institution Ciudad Autonoma de Buenos Aires Buenos Aires
Argentina Local Institution Ciudad Autonoma de Buenos Aires Buenos Aires
Argentina Local Institution Ciudad De Cordoba Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Cordoba
Argentina Local Institution Coronel Suarez Buenos Aires
Argentina Local Institution Corrientes
Argentina Local Institution Lanus Oeste Buenos Aires
Argentina Local Institution Mar del Plata Buenos Aires
Argentina Local Institution Mar Del Plata Buenos Aires
Argentina Local Institution Quilmes Buenos Aires
Argentina Local Institution Quilmes Buenos Aires
Argentina Local Institution Ramos Mejia Buenos Aires
Argentina Local Institution Ramos Mejia Buenos Aires
Argentina Local Institution Resistencia Chaco
Argentina Local Institution Rosario Santa FE
Argentina Local Institution Rosario Santa FE
Argentina Local Institution Rosario Santa FE
Argentina Local Institution Santa Fe
Argentina Local Institution Santa Fe
Argentina Local Institution Santa Fe
Argentina Local Institution Santiago Del Estero
Argentina Local Institution Vicente Lopez Buenos Aires
Argentina Local Institution Villa Allende Cordoba
Argentina Local Institution Villa Maria Cordoba
Australia Local Institution Bedford Park
Australia Local Institution Concord New South Wales
Australia Local Institution Elizabeth Vale South Australia
Australia Local Institution Milton Queensland
Australia Local Institution Port Macquarie New South Wales
Austria Local Institution Graz
Austria Local Institution Graz
Austria Local Institution Linz
Austria Local Institution Linz
Austria Local Institution Vienna
Austria Local Institution Wien
Austria Local Institution Wien
Belgium Local Institution Aalst
Belgium Local Institution Antwerpen
Belgium Local Institution Bonheiden
Belgium Local Institution Brasschaat
Belgium Local Institution Bruxelles
Belgium Local Institution Gent
Belgium Local Institution Ieper
Belgium Local Institution Leuven
Belgium Local Institution Wilrijk
Belgium Local Institution Yvoir
Brazil Local Institution Aparecida de Goiania Goias
Brazil Local Institution Belem Para
Brazil Local Institution Belo Horizonte Minas Gerais
Brazil Local Institution Belo Horizonte Minas Gerais
Brazil Local Institution Blumenau Santa Catarina
Brazil Local Institution Brasilia Distrito Federal
Brazil Local Institution Campina Grande Do Sul Parana
Brazil Local Institution Campinas SAO Paulo
Brazil Local Institution Canoas RIO Grande DO SUL
Brazil Local Institution Colatina Espirito Santo
Brazil Local Institution Goiania Goias
Brazil Local Institution Itajai Santa Catarina
Brazil Local Institution Limeira SAO Paulo
Brazil Local Institution Londrina Parana
Brazil Local Institution Marilia SAO Paulo
Brazil Local Institution Passo Fundo RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Porto Alegre RIO Grande DO SUL
Brazil Local Institution Recife Pernambuco
Brazil Local Institution Recife Pernambuco
Brazil Local Institution Rio de Janeiro
Brazil Local Institution S?o Paulo SAO Paulo
Brazil Local Institution S?o Paulo SAO Paulo
Brazil Local Institution S?o Paulo SAO Paulo
Brazil Local Institution Salvador Bahia
Brazil Local Institution Salvador Bahia
Brazil Local Institution Salvador Bahia
Brazil Local Institution Salvador Bahia
Brazil Local Institution Santo Andre SAO Paulo
Brazil Local Institution Sao Jose Do Rio Preto SAO Paulo
Brazil Local Institution Sao Paulo
Brazil Local Institution Sao Paulo
Brazil Local Institution Uberaba Minas Gerais
Brazil Local Institution Uberlandia Minas Gerais
Brazil Local Institution Votuporanga SAO Paulo
Bulgaria Local Institution Burgas
Bulgaria Local Institution Dimitrovgrad
Bulgaria Local Institution Haskovo
Bulgaria Local Institution Montana
Bulgaria Local Institution Pazardzhik
Bulgaria Local Institution Pleven
Bulgaria Local Institution Plovdiv
Bulgaria Local Institution Sandanski
Bulgaria Local Institution Smolyan
Bulgaria Local Institution Sofia
Bulgaria Local Institution Sofia
Bulgaria Local Institution Sofia
Bulgaria Local Institution Sofia
Bulgaria Local Institution Sofia
Bulgaria Local Institution Sofia
Bulgaria Local Institution Veliko Tarnova
Bulgaria Local Institution Vidin
Canada Local Institution Cambridge Ontario
Canada Local Institution Edmonton Alberta
Canada Local Institution Edmonton Alberta
Canada Local Institution Edmonton Alberta
Canada Local Institution Green Field Park Quebec
Canada Local Institution Halifax Nova Scotia
Canada Local Institution Kelowna British Columbia
Canada Local Institution Laval Quebec
Canada Local Institution London Ontario
Canada Local Institution Longueuil Quebec
Canada Local Institution Montreal Quebec
Canada Local Institution Montreal
Canada Local Institution New Westminster British Columbia
Canada Local Institution Oshawa Ontario
Canada Local Institution Regina Saskatchewan
Canada Local Institution Scarborough Ontario
Canada Local Institution Scarborough Ontario
Canada Local Institution Sherbrooke Quebec
Canada Local Institution St-Georges, Beauce Quebec
Canada Local Institution St-Jean-sur-Richelieu Quebec
Canada Local Institution St. Jerome Quebec
Canada Local Institution Sudbury Ontario
Canada Local Institution Sudbury Ontario
Canada Local Institution Victoria British Columbia
Canada Local Institution Waterloo Ontario
Canada Local Institution Winnepeg Manitoba
Chile Local Institution Santiago Metropolitana
Colombia Local Institution Barranquilla
Colombia Local Institution Barranquilla
Colombia Local Institution Bogota
Colombia Local Institution Cali
Colombia Local Institution Espinal
Colombia Local Institution Medellin
Croatia Local Institution Cakovec
Croatia Local Institution Dubrovnik
Croatia Local Institution Karlovac
Croatia Local Institution Krapinske toplice
Croatia Local Institution Opatija
Croatia Local Institution Osijek
Croatia Local Institution Rijeka
Croatia Local Institution Sibenik
Croatia Local Institution Slavonski Brod
Croatia Local Institution Virovitica
Croatia Local Institution Zabok
Croatia Local Institution Zadar
Croatia Local Institution Zagreb
Czechia Local Institution Prague 8
Czechia Local Institution Praha 2
Czechia Local Institution Praha 5
Czechia Local Institution Tabor
Czechia Local Institution Usti Nad Orlici
Czechia Local Institution Zlin
Denmark Local Institution Aabenraa
Denmark Local Institution Aarhus
Denmark Local Institution Copenhagen
Denmark Local Institution Frederiksburg
Denmark Local Institution Hellerup
Denmark Local Institution Hillerod
Denmark Local Institution Holb?k
Denmark Local Institution Hvidovre
Denmark Local Institution Randers
Denmark Local Institution Roskilde
Denmark Local Institution Slagelse
France Local Institution Besancon
France Local Institution Caen
France Local Institution Chambray-les-Tours
France Local Institution Le Coudray
France Local Institution Lyon
France Local Institution Marseille
France Local Institution Nimes
France Local Institution Pau
France Local Institution Pessac
France Local Institution Toulouse
Germany Local Institution Bad Friedrichshall
Germany Local Institution Bad Homburg
Germany Local Institution Bad Homburg
Germany Local Institution Berlin
Germany Local Institution Berlin
Germany Local Institution Berlin
Germany Local Institution Bielefeld
Germany Local Institution Brandenburg
Germany Local Institution Bremen
Germany Local Institution Chemnitz
Germany Local Institution Dortmund
Germany Local Institution Dresden
Germany Local Institution Dresden
Germany Local Institution Erfurt
Germany Local Institution Erfurt
Germany Local Institution Erlangen
Germany Local Institution Essen
Germany Local Institution Frankfurt am Main
Germany Local Institution Freiburg
Germany Local Institution Gottingen
Germany Local Institution Greifswald
Germany Local Institution Hamburg
Germany Local Institution Hamburg
Germany Local Institution Hansestadt Stendal
Germany Local Institution Hennigsdorf
Germany Local Institution Hoyerswerda
Germany Local Institution Jena
Germany Local Institution Karlsbad
Germany Local Institution Kassel
Germany Local Institution Koln
Germany Local Institution Lahr
Germany Local Institution Leipzig
Germany Local Institution Limburg
Germany Local Institution Ludenscheid
Germany Local Institution Luebeck
Germany Local Institution Magdeburg
Germany Local Institution Mainz
Germany Local Institution Mannheim
Germany Local Institution Neuss
Germany Local Institution Papenburg
Germany Local Institution Regensburg
Germany Local Institution Rostock
Germany Local Institution Straubing
Germany Local Institution Tubingen
Germany Local Institution Ulm
Germany Local Institution Villingen-Schwenningen
Germany Local Institution Weiden i.d.OPf.
Germany Local Institution Worms
Germany Local Institution Wurzburg
Hungary Local Institution Baja Bacs-kiskun
Hungary Local Institution Bekescsaba
Hungary Local Institution Budapest
Hungary Local Institution Budapest
Hungary Local Institution Budapest
Hungary Local Institution Budapest
Hungary Local Institution Budapest
Hungary Local Institution Budapest
Hungary Local Institution Keszthely
Hungary Local Institution Mosonmagyarovar
Hungary Local Institution Pecs
Hungary Local Institution Pecs
Hungary Local Institution Szeged
Hungary Local Institution Szekszard
Hungary Local Institution Szolnok
India Local Institution Ahmedabad Gujarat
India Local Institution Amritsar
India Local Institution Bangalore Karnataka
India Local Institution Jaipur,
India Local Institution Lucknow
India Local Institution Madurai
India Local Institution Mangalore
India Local Institution New Delhi
India Local Institution New Delhi
India Local Institution Noida
India Local Institution Shivamogga
India Local Institution Vadodara
India Local Institution Vijayawada
Israel Local Institution Afula
Israel Local Institution Ashkelon
Israel Local Institution Hadera
Israel Local Institution Haifa
Israel Local Institution Haifa
Israel Local Institution Haifa
Israel Local Institution Herzliya
Israel Local Institution Holon
Israel Local Institution Jerusalem
Israel Local Institution Ramat-Gan
Israel Local Institution Rehovot
Israel Local Institution Safed
Israel Local Institution Tel Aviv
Israel Local Institution Tiberias
Italy Local Institution Grosseto
Korea, Republic of Local Institution Busan
Korea, Republic of Local Institution Changwon
Korea, Republic of Local Institution Daegu
Korea, Republic of Local Institution Daegu
Korea, Republic of Local Institution Daejeon
Korea, Republic of Local Institution Gwang Ju
Korea, Republic of Local Institution Incheon
Korea, Republic of Local Institution Seongnam-si
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Korea, Republic of Local Institution Seoul
Mexico Local Institution Aguascalientes
Mexico Local Institution Culiacan Sinaloa
Mexico Local Institution Durango
Mexico Local Institution Guadalajara Jalisco
Mexico Local Institution Leon Guanajuato
Mexico Local Institution Monterrey Nuevo LEON
Mexico Local Institution Puebla
Mexico Local Institution Queretaro QUE
Mexico Local Institution San Juan del Rio Queretaro
Mexico Local Institution San Luis Potosi
Mexico Local Institution San Luis Potosi
Mexico Local Institution Tlalnepantla De Baz
Mexico Local Institution Torreon Coahuila
Mexico Local Institution Veracruz
Netherlands Local Institution Amsterdam
Netherlands Local Institution Amsterdam
Netherlands Local Institution Arnhem
Netherlands Local Institution Breda
Netherlands Local Institution Ede
Netherlands Local Institution Groningen
Netherlands Local Institution Hardenberg
Netherlands Local Institution Maastricht
Netherlands Local Institution Nieuwegein
Netherlands Local Institution Rotterdam
Netherlands Local Institution Tilburg
Netherlands Local Institution Uden
Norway Local Institution Bod?
Norway Local Institution Oslo
Norway Local Institution Oslo
Norway Local Institution Skien
Norway Local Institution Stavanger
Norway Local Institution Tromso
Peru Local Institution Callao
Peru Local Institution Callao
Peru Local Institution Cusco
Peru Local Institution Lima
Peru Local Institution Lima
Peru Local Institution Miraflores Lima
Poland Local Institution Bialystok
Poland Local Institution Bydgoszcz
Poland Local Institution Bytom
Poland Local Institution Chojnice
Poland Local Institution Gdynia
Poland Local Institution Gdynia
Poland Local Institution Katowice
Poland Local Institution Kielce
Poland Local Institution Krakow
Poland Local Institution Krakow
Poland Local Institution Krakow
Poland Local Institution Lodz
Poland Local Institution Lodz
Poland Local Institution Lodz
Poland Local Institution Lubin
Poland Local Institution Opole
Poland Local Institution Plock
Poland Local Institution Poznan Wielkopolskie
Poland Local Institution Siemianowice Slaskie
Poland Local Institution Torun
Poland Local Institution Warszawa
Poland Local Institution Warszawa
Poland Local Institution Wloclawek
Poland Local Institution Wroclaw
Poland Local Institution Wroclaw
Portugal Local Institution Almada
Portugal Local Institution Aveiro
Portugal Local Institution Braga
Portugal Local Institution Coimbra
Portugal Local Institution Covilha
Portugal Local Institution Guimar?es
Portugal Local Institution Leiria
Portugal Local Institution Lisbon
Portugal Local Institution Senhora De Hora, Matosinhos
Portugal Local Institution Vila Real
Puerto Rico Local Institution Caguas
Romania Local Institution Baia Mare
Romania Local Institution Brasov
Romania Local Institution Bucharest
Romania Local Institution Bucharest
Romania Local Institution Cluj-Napoca
Romania Local Institution Cluj-Napoca
Romania Local Institution Craiova
Romania Local Institution Oradea
Romania Local Institution Pitesti
Romania Local Institution Sibiu
Romania Local Institution Targoviste
Romania Local Institution Targu Mures
Romania Local Institution Timisoara
Romania Local Institution Timisoara
Romania Local Institution Tirgu Mures
Russian Federation Local Institution Ekaterinburg
Russian Federation Local Institution Gatchina
Russian Federation Local Institution Kazan
Russian Federation Local Institution Krasnodar
Russian Federation Local Institution Krasnodar
Russian Federation Local Institution Moscow
Russian Federation Local Institution Moscow
Russian Federation Local Institution Moscow
Russian Federation Local Institution Moscow
Russian Federation Local Institution Novosibirsk
Russian Federation Local Institution Novosibirsk
Russian Federation Local Institution Saint Petersburg
Russian Federation Local Institution Samara
Russian Federation Local Institution Saratov
Russian Federation Local Institution Saratov
Russian Federation Local Institution Sochi
Russian Federation Local Institution St. Petersburg
Russian Federation Local Institution St. Petersburg
Russian Federation Local Institution St. Petersburg
Russian Federation Local Institution St. Petersburg
Russian Federation Local Institution St. Petersburg
Russian Federation Local Institution Tyumen
Russian Federation Local Institution Tyumen
Serbia Local Institution Belgarde
Serbia Local Institution Belgrade
Serbia Local Institution Belgrade
Serbia Local Institution Nis
Serbia Local Institution Sremska Kamenica
Serbia Local Institution Uzice
Slovakia Local Institution Banska Bystrica
Slovakia Local Institution Bardejov
Slovakia Local Institution Bratislava
Slovakia Local Institution Bratislava
Slovakia Local Institution Brezno
Slovakia Local Institution Kosice
Slovakia Local Institution Kosice
Slovakia Local Institution Kosice
Slovakia Local Institution Nitra
Slovakia Local Institution Spisska Nova Ves
Slovakia Local Institution Trebisov
Slovakia Local Institution Trencin
Spain Local Institution Alicante
Spain Local Institution Barcelona
Spain Local Institution Cordoba
Spain Local Institution Huelva
Spain Local Institution Madrid
Spain Local Institution Madrid
Spain Local Institution Madrid
Spain Local Institution Madrid
Spain Local Institution Majadahonda Madrid
Spain Local Institution Malaga
Spain Local Institution Marbella
Spain Local Institution Palma de Mallorca
Spain Local Institution San Sebastian
Spain Local Institution Valencia
Spain Local Institution Valencia
Sweden Local Institution Eskilstuna
Sweden Local Institution Goteborg
Sweden Local Institution Jonkoping
Sweden Local Institution Ostersund
Sweden Local Institution Skelleftea
Sweden Local Institution Stockholm
Sweden Local Institution Uppsala
Switzerland Local Institution Bern
Switzerland Local Institution Geneva
Switzerland Local Institution Winterthur
Ukraine Local Institution Cherkasy
Ukraine Local Institution Chernivtsi
Ukraine Local Institution Dnipropetrovsk
Ukraine Local Institution Ivano-Frankivsk
Ukraine Local Institution Kharkiv
Ukraine Local Institution Kharkiv
Ukraine Local Institution Kharkiv
Ukraine Local Institution Kyiv
Ukraine Local Institution Kyiv
Ukraine Local Institution Kyiv
Ukraine Local Institution Lutsk
Ukraine Local Institution Lutsk
Ukraine Local Institution Mykolaiv
Ukraine Local Institution Odesa
Ukraine Local Institution Uzhhorod
Ukraine Local Institution Vinnytsia
Ukraine Local Institution Vinnytsia
Ukraine Local Institution Zhaporizhzhya
United Kingdom Local Institution Birmingham
United Kingdom Local Institution Bournemouth Dorset
United Kingdom Local Institution Doncaster South Yorkshire
United Kingdom Local Institution Dudley, West Midlands
United Kingdom Local Institution Dundee
United Kingdom Local Institution Kirkcaldy Fife
United Kingdom Local Institution Liverpool Merseyside
United Kingdom Local Institution Northampton Northamptonshire
United Kingdom Local Institution Sheffield South Yorkshire
United Kingdom Local Institution Stevenage Hertfordshire
United Kingdom Local Institution Wolverhampton
United States Capital Cardiology Associates Albany New York
United States Alexandria Cardiology Clinic Alexandria Louisiana
United States Comprehensive Cardiovascular Specialists Alhambra California
United States Great Lakes Heart Center of Alpena Alpena Michigan
United States Orlando Heart Specialists Altamonte Springs Florida
United States Local Institution Ann Arbor Michigan
United States Asheville Cardiology Associates PA Asheville North Carolina
United States Athens Regional Cariology Group Athens Georgia
United States Local Institution Atlanta Georgia
United States Augusta University Augusta Georgia
United States University Of Colorado Aurora Colorado
United States Local Institution Austin Texas
United States Local Institution Austin Texas
United States Local Institution Billings Montana
United States Cardiovascular Associates of the Southeast, LLC Birmingham Alabama
United States University of Alabama at Birmingham Birmingham Alabama
United States Local Institution Bloomington Indiana
United States Saint Lukes Idaho Cardiology Associates Boise Idaho
United States Local Institution Bradenton Florida
United States Local Institution Brooklyn New York
United States New York-Presbyterian Brooklyn Methodist Hospital Brooklyn New York
United States Buffalo Heart Group LLP Buffalo New York
United States University of Vermont Burlington Vermont
United States Aultman Hospital Canton Ohio
United States University of North Carolina School of Medicine Chapel Hill North Carolina
United States Clearwater Cardiovascular and Interventional Consultants Clearwater Florida
United States Local Institution Clearwater Florida
United States Columbia Heart Columbia South Carolina
United States Local Institution Columbia Missouri
United States Missouri Cardiovascular Specialists Columbia Missouri
United States Local Institution Columbus Ohio
United States Georgia Heart Specialists Covington Georgia
United States Saint Elizabeth Healthcare Crestview Hills Kentucky
United States Local Institution Culver City California
United States Local Institution Cumming Georgia
United States Local Institution Dallas Texas
United States Midwest Cardiovascular Research Foundation Davenport Iowa
United States Daytona Heart Group Daytona Beach Florida
United States Henry Ford Hospital Detroit Michigan
United States Local Institution Detroit Michigan
United States Duke University Medical Center Durham North Carolina
United States Durham VA Medical Center Durham North Carolina
United States Elkhart Clinic LLC Elkhart Indiana
United States Saint Vincent Hospital Erie Pennsylvania
United States Medicoricium, LLC Fairview Heights Illinois
United States Virginia Heart Falls Church Virginia
United States Local Institution Fort Lauderdale Florida
United States San Antonio Military Medical Center Fort Sam Houston Texas
United States Washington Township Medical Foundation Fremont California
United States Local Institution Germantown Tennessee
United States Upstate Cardiology PA Greenville South Carolina
United States Hattiesburg Clinic Hattiesburg Mississippi
United States Angiocardiac Care of Texas PA Houston Texas
United States Local Institution Houston Texas
United States Local Institution Houston Texas
United States St Mary's Medical Center Huntington West Virginia
United States California Heart Specialist, Inc. Huntington Beach California
United States Grace Research, LLC Huntsville Texas
United States Local Institution Huntsville Texas
United States Roudebush VA Medical Center Indianapolis Indiana
United States University of Iowa Stead Family Children's Hospital Iowa City Iowa
United States Local Institution Jackson Mississippi
United States Research Associates of Jackson Jackson Tennessee
United States Local Institution Jacksonville Florida
United States Local Institution Jacksonville Florida
United States Local Institution Jacksonville Beach Florida
United States Gateway Cardiology PC Jerseyville Illinois
United States Freeman Health System Joplin Missouri
United States Tenet Florida Physician Services Jupiter Florida
United States Local Institution Kansas City Kansas
United States Local Institution Katy Texas
United States Local Institution Kettering Ohio
United States Cardiovascular Research of Knoxville Knoxville Tennessee
United States Knoxville Health Managment Associates Cardiology PPM LLC Knoxville Tennessee
United States Foundation For Cardiovascular Medicine La Jolla California
United States Imperial Health Lake Charles Louisiana
United States Local Institution Lake Mary Florida
United States Colorado Heart and Vascular Lakewood Colorado
United States Heart Group Lancaster Pennsylvania
United States Local Institution Lansing Michigan
United States HCP Clinical Research LLC Las Vegas Nevada
United States Virginia Heart Group Ltd Leesburg Virginia
United States Clinical Trials of America-NC, LLC - PPDS Lenoir North Carolina
United States Bryan Heart Hospital Lincoln Nebraska
United States New Jersey Heart Linden New Jersey
United States Local Institution Little Rock Arkansas
United States Local Institution Long Beach California
United States University of Louisville Louisville Kentucky
United States Caprock Cardiac Center Research Institute Lubbock Texas
United States Duke Cardiology and Cardiovascular Surgery of Lumberton Lumberton North Carolina
United States Local Institution Miami Florida
United States Local Institution Minden Louisiana
United States Metropolitan Cardiology Consultants Minneapolis Minnesota
United States Clinical Trials of America LA LLC - PPDS Monroe Louisiana
United States Local Institution Natick Massachusetts
United States Mount Sinai-St. Lukes New York New York
United States Mercer Bucks Cardiology Newton Pennsylvania
United States Advocate Medical Group ? Cardiology and Pulmonology Normal Illinois
United States Roper St. Francis Healthcare North Charleston South Carolina
United States Local Institution Norwalk Connecticut
United States Parkway Cardiology Associates PC Oak Ridge Tennessee
United States Mediquest Research Ocala Florida
United States South Suburban Cardiology Olympia Fields Illinois
United States Local Institution Orlando Florida
United States CP Cardiology Partners Palm Beach Gardens Florida
United States Arizona Heart Rhythm Center Phoenix Arizona
United States Local Institution Phoenix Arizona
United States Local Institution Phoenix Arkansas
United States Local Institution Plano Texas
United States Hudson Valley Cardiovascular Practice, PC Poughkeepsie New York
United States Rhode Island Hospital Providence Rhode Island
United States Local Institution Rancho Mirage California
United States Renown Regional Medical Center. Reno Nevada
United States CJW Medical Center Richmond Virginia
United States Reid Hospital and Health Care Services Richmond Indiana
United States Carolina Cardiology Clinical Research Institute Rock Hill South Carolina
United States Covenant Center for the Heart Saginaw Michigan
United States Gateway Cardiology PC Saint Louis Missouri
United States St. Louis Heart and Vascular Saint Louis Missouri
United States Bayfront Health St. Petersburg Saint Petersburg Florida
United States Local Institution San Antonio Texas
United States Mercury Medical LLC San Antonio Texas
United States Local Institution San Diego California
United States Scottsdale Osborn Medical Center Scottsdale Arizona
United States Local Institution Sealy Texas
United States Virginia Mason Medical Center Seattle Washington
United States Cox Health Systems Springfield Missouri
United States Manshadi Heart Institute Stockton California
United States Local Institution Sugar Land Texas
United States Local Institution Tampa Florida
United States Local Institution Torrance California
United States Local Institution Tucker Georgia
United States Southern Arizona VA Health Care System Tucson Arizona
United States Cardiology Associates Research LLC Tupelo Mississippi
United States Victoria Heart and Vascular Center Victoria Texas
United States Northeast Iowa Family Practice Center Waterloo Iowa
United States Aspirus Research Institute Wausau Wisconsin
United States Cardiology Partners Wellington Florida
United States Local Institution Wichita Kansas
United States Local Institution Willoughby Ohio
United States Local Institution Wilmington Delaware
United States PMG Research of Wilmington Wilmington North Carolina
United States WellSpan York Hospital York Pennsylvania
Virgin Islands (U.S.) Local Institution Christiansted

Sponsors (3)

Lead Sponsor Collaborator
Bristol-Myers Squibb Duke Clinical Research Institute, Pfizer

Countries where clinical trial is conducted

United States,  Virgin Islands (U.S.),  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Bulgaria,  Canada,  Chile,  Colombia,  Croatia,  Czechia,  Denmark,  France,  Germany,  Hungary,  India,  Israel,  Italy,  Korea, Republic of,  Mexico,  Netherlands,  Norway,  Peru,  Poland,  Portugal,  Puerto Rico,  Romania,  Russian Federation,  Serbia,  Slovakia,  Spain,  Sweden,  Switzerland,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Rate of International Society on Thrombosis and Haemostasis (ISTH) Major or Clinically Relevant Non-Major (CRNM) Bleeding With Apixaban Versus Vitamin K Antagonist (VKA) During the Treatment Period Time to first ISTH major or CRNM bleeding during the 6-month period of treatment with Apixaban or VKA.
N is the number of participants treated with Apixaban or VKA.
n is the number of participants treated with Apixaban or VKA with major or CRNM bleeding in each treatment group during the 6-month period of treatment.
Event rates are calculated based on the number of participants with major or CRNM bleeding divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Primary The Rate of ISTH Major or CRNM Bleeding With Aspirin Versus no Aspirin During the Treatment Period Time to first ISTH major or CRNM bleeding during the treatment period of 6 months with aspirin or placebo.
N is the number of participants with aspirin or placebo.
n is the number of participants treated with aspirin or placebo with major or CRNM bleeding in each treatment group during the 6-month period of treatment.
Event rates are calculated based on the number of participants with event of interest divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Secondary Superiority on ISTH Major or CRNM Bleeding for Apixaban Versus VKA Time to first occurrence during the time the participants were treated with Apixaban or VKA.
N is the number of participants treated with Apixaban or VKA.
n is the number of participants treated with Apixaban or VKA with major or CRNM bleeding in each treatment group during the 6-month period of treatment.
Event rates are calculated based on the number of participants with event of interest divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Secondary The Rate of All-cause Death or All-cause Rehospitalization With Apixaban Versus VKA Time to first all-cause death or all-cause hospitalization during the during the 6-month treatment period with Apixaban or VKA.
N is the number of participants treated with Apixaban or VKA.
n is the number of participants treated with Apixaban or VKA with all-cause death or all-cause hospitalization in each treatment group during the 6-month period of treatment.
Event rates are calculated based on the number of participants with all-cause death or all-cause hospitalization divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Secondary The Rate of All-cause Death or All-cause Rehospitalization With Aspirn Versus no Aspirin Time to first all-cause death or all-cause hospitalization during the 6-month period of treatment with aspirin or placebo.
N is the number of participants treated with aspirin or placebo.
n is the number of participants treated with aspirin or placebo with all-cause death or all-cause hospitalization in each treatment group during the 6-month period of treatment.
Event rates are calculated based on the number of participants with all-cause death or all-cause hospitalization divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Secondary The Rate of the Composite Endpoint of Death or Ischemic Events (Stroke, Myocardial Infarction, Stent Thrombosis, Urgent Revascularization) With Apixaban Versus VKA Time to first occurrence during the 6-month treatment period with Apixaban or VKA.
N is the number of participants treated with Apixaban or VKA.
n is the number of participants treated with Apixaban or VKA with death or ischemic events in each treatment group during the during the 6-month period of treatment.
Event rates are calculated based on the number of participants with death or ischemic events divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
Secondary The Composite Endpoints of Death and Ischemic Events (Stroke, Myocardial Infarction, Stent Thrombosis, Urgent Revascularization) With Aspirin Versus no Aspirin Time to first death or ischenic event during the 6-month treatment period with aspirin or placebo.
N is the number of participants treated with aspirin or placebo.
n is the number of participants treated with aspirin or placebo with death or ischemic events in each treatment group during the 6-month treatment period.
Event rates are calculated based on the number of participants with death or ischemic events divided by the sum of the number of days from the first dose of study drug to the event date or censoring date and expressed as percentage per year.
Approximately 6 months
See also
  Status Clinical Trial Phase
Completed NCT02552407 - Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis N/A
Completed NCT01398228 - Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 N/A
Completed NCT01135667 - Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI Phase 4
Recruiting NCT02592720 - Cocktail Injection Improves Outcomes of FFR Guided PCI Phase 4
Completed NCT01641510 - PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants Phase 3
Completed NCT01743274 - Does Optical Coherence Tomography Optimise Results of Stenting N/A
Active, not recruiting NCT01433627 - Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX Phase 3
Completed NCT01452282 - Ankle-Brachial Index Estimating Cardiac Complications After Surgery N/A
Recruiting NCT01418794 - Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Phase 4
Recruiting NCT01000701 - Inflammation and Acute Coronary Syndromes N/A
Terminated NCT01107899 - Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes Phase 1
Completed NCT00494247 - Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes Phase 4
Terminated NCT00615719 - Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation N/A
Active, not recruiting NCT06089343 - High-risk Features of Coronary Lesions in CTA and OCT
Not yet recruiting NCT04023630 - DUAL Antithrombotic Therapy in Patients With AF and ACS Phase 4
Recruiting NCT02601404 - REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD) N/A
Completed NCT02195193 - Integrating Depression Care in Acute Coronary Syndromes Care in China N/A
Completed NCT02141750 - THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES N/A
Not yet recruiting NCT01735227 - Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Phase 4
Completed NCT00097591 - A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention Phase 3